https://scholars.lib.ntu.edu.tw/handle/123456789/628465
標題: | Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan | 作者: | CHEN-HUA LIU Peng, Cheng-Yuan CHUN-JEN LIU Chen, Chi-Yi Lo, Ching-Chu Tseng, Kuo-Chih Su, Pei-Yuan Kao, Wei-Yu Tsai, Ming-Chang Tung, Hung-Da Cheng, Hao-Tsai Lee, Fu-Jen Huang, Chia-Sheng Huang, Ke-Jhang Shih, Yu-Lueng Yang, Sheng-Shun Wu, Jo-Hsuan Lai, Hsueh-Chou YU-JEN FANG Chen, Po-Yueh Hwang, Jow-Jyh Tseng, Chi-Wei Su, Wei-Wen Chang, Chun-Chao Lee, Pei-Lun Chen, Jyh-Jou Chang, Chi-Yang Hsieh, Tsai-Yuan Chang, Chung-Hsin Huang, Yi-Jie JIA-HORNG KAO |
關鍵字: | Direct-acting antiviral; Effectiveness; Hepatitis C virus; Pangenotypic; Resistance-associated substitution; Safety; Sofosbuvir; Sustained virologic response; Velpatasvir; Voxilaprevir | 公開日期: | 26-一月-2023 | 出版社: | SPRINGER | 來源出版物: | Hepatology international | 摘要: | Real-world data are scarce about the effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for retreating East Asian patients with hepatitis C virus (HCV) infection who previously received NS5A direct-acting antivirals (DAAs). We conducted a multicenter study to assess the performance of SOF/VEL/VOX in patients who were not responsive to prior NS5A inhibitors in Taiwan. |
URI: | https://www.scopus.com/record/display.uri?eid=2-s2.0-85146835856&doi=10.1007%2fs12072-022-10475-9&origin=inward&txGid=e92efd61e1ac6dffcbb4ab31c8adaeb6 https://scholars.lib.ntu.edu.tw/handle/123456789/628465 |
ISSN: | 1936-0533 | DOI: | 10.1007/s12072-022-10475-9 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。